 
                    
                Navamedic
Nordic provider of specialty pharma, generics & nutrition to hospitals and pharmacies.
NAVA | OL
Overview
Corporate Details
- ISIN(s):
- NO0010205966
- LEI:
- 529900LKVQOR2SRUJU71
- Country:
- Norway
- Address:
- Henrik Ibsens gate 100, 0255 OSLO
- Website:
- https://navamedic.com/
- Sector:
- Wholesale and retail trade
- Industry:
- Wholesale of household goods
Description
Navamedic is a Nordic pharmaceutical company that acts as a full-service provider of high-quality healthcare products, supplying both hospitals and pharmacies. The company's portfolio includes specialty pharmaceuticals, branded generics, and medical nutrition products. Its core therapeutic areas focus on antibiotics, obesity, Parkinson's disorder, and inborn errors of metabolism. Committed to improving public health, Navamedic partners with global pharmaceutical companies to bring products to the Nordic market and has recently expanded into addiction treatment and launched new over-the-counter topical treatments.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-28 07:00 | Investor Presentation Navamedic ASA: Double digit growth in the 3rd quarter, 2025 - Attachment: Navam… | English | 2.9 MB | ||
| 2025-10-28 07:00 | Investor Presentation Navamedic ASA: Tosifret vekst i tredje kvartal 2025 - Attachment: Navamedic_Q3_… | English | 2.9 MB | ||
| 2025-10-28 07:00 | Earnings Release Navamedic ASA: Double digit growth in the 3rd quarter, 2025 | English | 4.8 KB | ||
| 2025-10-28 07:00 | Earnings Release Navamedic ASA: Tosifret vekst i tredje kvartal 2025 | Norwegian | 4.8 KB | ||
| 2025-10-24 17:56 | Report Publication Announcement Navamedic ASA: Invitation to 2025 3rd quarter presentation | English | 2.0 KB | ||
| 2025-10-17 11:22 | Regulatory News Service Navamedic ASA: Navamedic extends its business into Germany together with Evolsi… | English | 4.2 KB | ||
| 2025-10-15 13:46 | Major Shareholding Notification NOTIFICATION OF MAJOR HOLDINGS - Attachment: 2025-10-15_major_shareholder_discl… | English | 310.0 KB | ||
| 2025-10-15 13:46 | Major Shareholding Notification NOTIFICATION OF MAJOR HOLDINGS | English | 266 bytes | ||
| 2025-10-14 14:38 | Major Shareholding Notification Flaggemelding NAVA | Norwegian | 661 bytes | ||
| 2025-10-13 18:26 | Share Issue/Capital Change Navamedic ASA - New share capital registered | English | 2.2 KB | ||
| 2025-10-07 15:51 | Major Shareholding Notification Notification of major shareholding | English | 1.7 KB | ||
| 2025-10-07 12:55 | Director's Dealing Navamedic ASA: Allocation of shares in the rights issue to primary insiders and… | English | 151.3 KB | ||
| 2025-10-07 12:55 | Share Issue/Capital Change Navamedic ASA: Allocation of shares in the rights issue to primary insiders and… | English | 1.7 KB | ||
| 2025-10-07 12:42 | Share Issue/Capital Change Navamedic ASA: Final results of the rights issue | English | 12.3 KB | ||
| 2025-10-06 20:47 | Share Issue/Capital Change Navamedic ASA: Preliminary results of the rights issue | English | 10.3 KB | 
Automate Your Workflow. Get a real-time feed of all Navamedic filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Navamedic
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Navamedic via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value | 
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
 
                                        
                                     
                                        
                                     
                                        
                                     
                                        
                                     
                                        
                                     
                                        
                                     
                                        
                                    